🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Treatment Gaining Traction Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where communities with numerous of members share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors promote the drug there before redirecting customers to other platforms for transactions.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, physicians and chemists have warned that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in users injecting products of uncertain source.

Some experts stated the popularity for the experimental drug could be linked to the rising price of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and customer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Material Elimination

Based on the social media company, the platform has taken down violative content and prohibited related hashtags and query recommendations. The organization said it was committed to keeping the platform safe and investing in strengthening enforcement strategies.

Online Marketplace Activities

Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or injecting at residence.

Within minutes of entering one group, a vendor posted contact information, where most purchases occur. The vendor provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or previous experience.

Item Details and Costs

Within these communities, posts show dark colored packages with Royal Mail labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20 milligrams. When questioned how much time a injector should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is sound, these online products may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company experimental substance not yet approved … may expose patients to possibly serious medical dangers”.